207 related articles for article (PubMed ID: 28713672)
1.
Cheung M; Testa JR
Transl Lung Cancer Res; 2017 Jun; 6(3):270-278. PubMed ID: 28713672
[TBL] [Abstract][Full Text] [Related]
2. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.
Carbone M; Ferris LK; Baumann F; Napolitano A; Lum CA; Flores EG; Gaudino G; Powers A; Bryant-Greenwood P; Krausz T; Hyjek E; Tate R; Friedberg J; Weigel T; Pass HI; Yang H
J Transl Med; 2012 Aug; 10():179. PubMed ID: 22935333
[TBL] [Abstract][Full Text] [Related]
3. Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines.
Chau C; van Doorn R; van Poppelen NM; van der Stoep N; Mensenkamp AR; Sijmons RH; van Paassen BW; van den Ouweland AMW; Naus NC; van der Hout AH; Potjer TP; Bleeker FE; Wevers MR; van Hest LP; Jongmans MCJ; Marinkovic M; Bleeker JC; Jager MJ; Luyten GPM; Nielsen M
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31382694
[TBL] [Abstract][Full Text] [Related]
4. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
[TBL] [Abstract][Full Text] [Related]
5. BAP1 germline variants in Finnish patients with malignant mesothelioma.
Repo P; Staskiewicz A; Sutinen E; Rönty M; Tero T Kivelä ; Myllärniemi M; Turunen JA
Lung Cancer; 2022 Mar; 165():102-107. PubMed ID: 35114507
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.
Betti M; Aspesi A; Ferrante D; Sculco M; Righi L; Mirabelli D; Napoli F; Rondón-Lagos M; Casalone E; Vignolo Lutati F; Ogliara P; Bironzo P; Gironi CL; Savoia P; Maffè A; Ungari S; Grosso F; Libener R; Boldorini R; Valiante M; Pasini B; Matullo G; Scagliotti G; Magnani C; Dianzani I
Genes Chromosomes Cancer; 2018 Nov; 57(11):573-583. PubMed ID: 30338612
[TBL] [Abstract][Full Text] [Related]
7. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
[TBL] [Abstract][Full Text] [Related]
8. Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients.
Cebulla CM; Binkley EM; Pilarski R; Massengill JB; Rai K; Liebner DA; Marino MJ; Singh AD; Abdel-Rahman MH
Ophthalmic Genet; 2015 Jun; 36(2):126-31. PubMed ID: 25687217
[TBL] [Abstract][Full Text] [Related]
9. Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma.
Masoomian B; Shields JA; Shields CL
J Curr Ophthalmol; 2018 Jun; 30(2):102-109. PubMed ID: 29988936
[TBL] [Abstract][Full Text] [Related]
10. Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations.
Kadariya Y; Cheung M; Xu J; Pei J; Sementino E; Menges CW; Cai KQ; Rauscher FJ; Klein-Szanto AJ; Testa JR
Cancer Res; 2016 May; 76(9):2836-44. PubMed ID: 26896281
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.
Rai K; Pilarski R; Cebulla CM; Abdel-Rahman MH
Clin Genet; 2016 Mar; 89(3):285-94. PubMed ID: 26096145
[TBL] [Abstract][Full Text] [Related]
12. Diagnostics of
Sculco M; La Vecchia M; Aspesi A; Clavenna MG; Salvo M; Borgonovi G; Pittaro A; Witel G; Napoli F; Listì A; Grosso F; Libener R; Maconi A; Rena O; Boldorini R; Giachino D; Bironzo P; Maffè A; Alì G; Elefanti L; Menin C; Righi L; Tampieri C; Scagliotti GV; Dianzani C; Ferrante D; Migliore E; Magnani C; Mirabelli D; Matullo G; Dianzani I
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885614
[TBL] [Abstract][Full Text] [Related]
13. BAP1 mutations in high-grade meningioma: implications for patient care.
Shankar GM; Santagata S
Neuro Oncol; 2017 Oct; 19(11):1447-1456. PubMed ID: 28482042
[TBL] [Abstract][Full Text] [Related]
14. Basal cell carcinomas developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with BAP1-TPDS.
Melzer C; Sharma A; Peters S; Aretz S; Biswas A; Holz FG; Loeffler KU; Herwig-Carl MC
Genes Chromosomes Cancer; 2019 Jun; 58(6):357-364. PubMed ID: 30578689
[TBL] [Abstract][Full Text] [Related]
15. The Importance of Multidisciplinary Approach in Early Detection of BAP1 Tumor Predisposition Syndrome: Clinical Management and Risk Assessment.
Battaglia A
Clin Med Insights Oncol; 2014; 8():37-47. PubMed ID: 24855403
[TBL] [Abstract][Full Text] [Related]
16. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.
Field MG; Kuznetsov JN; Bussies PL; Cai LZ; Alawa KA; Decatur CL; Kurtenbach S; Harbour JW
Clin Cancer Res; 2019 Sep; 25(18):5663-5673. PubMed ID: 31285370
[TBL] [Abstract][Full Text] [Related]
17. Population-based analysis of BAP1 germline variations in patients with uveal melanoma.
Repo P; Järvinen RS; Jäntti JE; Markkinen S; Täll M; Raivio V; Turunen JA; Kivelä TT
Hum Mol Genet; 2019 Jul; 28(14):2415-2426. PubMed ID: 31058963
[TBL] [Abstract][Full Text] [Related]
18. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
Marušić Z; Buljan M; Busam KJ
J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
[TBL] [Abstract][Full Text] [Related]
19. Tumours associated with BAP1 mutations.
Murali R; Wiesner T; Scolyer RA
Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
[TBL] [Abstract][Full Text] [Related]
20. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.
Martorano LM; Winkelmann RR; Cebulla CM; Abdel-Rahman MH; Campbell SM
Int J Dermatol; 2014 Jun; 53(6):657-63. PubMed ID: 24697775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
